APA (7th ed.) Citation

P, C., W, M., F, L., A, A., V, P., C, V., . . . O, A. (2018). Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy. The oncologist, 23(6), 670. https://doi.org/10.1634/theoncologist.2017-0396

Chicago Style (17th ed.) Citation

P, Cabrera-Galeana, et al. "Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy." The Oncologist 23, no. 6 (2018): 670. https://doi.org/10.1634/theoncologist.2017-0396.

MLA (9th ed.) Citation

P, Cabrera-Galeana, et al. "Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy." The Oncologist, vol. 23, no. 6, 2018, p. 670, https://doi.org/10.1634/theoncologist.2017-0396.